TR200002248T2 - Yeni dihidroksiheksanoik asit türevleri - Google Patents

Yeni dihidroksiheksanoik asit türevleri

Info

Publication number
TR200002248T2
TR200002248T2 TR2000/02248T TR200002248T TR200002248T2 TR 200002248 T2 TR200002248 T2 TR 200002248T2 TR 2000/02248 T TR2000/02248 T TR 2000/02248T TR 200002248 T TR200002248 T TR 200002248T TR 200002248 T2 TR200002248 T2 TR 200002248T2
Authority
TR
Turkey
Prior art keywords
acid derivatives
new
dihydroxyhexanoic acid
dihydroxyhexanoic
inflammation
Prior art date
Application number
TR2000/02248T
Other languages
English (en)
Turkish (tr)
Inventor
Charles Kath John
Frank Brown Matthew
Stanley Poss Christopher
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200002248T2 publication Critical patent/TR200002248T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
TR2000/02248T 1998-02-05 1999-01-18 Yeni dihidroksiheksanoik asit türevleri TR200002248T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05

Publications (1)

Publication Number Publication Date
TR200002248T2 true TR200002248T2 (tr) 2000-12-21

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02248T TR200002248T2 (tr) 1998-02-05 1999-01-18 Yeni dihidroksiheksanoik asit türevleri

Country Status (36)

Country Link
EP (1) EP1051405B1 (enExample)
JP (1) JP3693916B2 (enExample)
KR (1) KR100385529B1 (enExample)
CN (1) CN1177834C (enExample)
AP (1) AP992A (enExample)
AR (1) AR016175A1 (enExample)
AT (1) ATE337307T1 (enExample)
AU (1) AU752407B2 (enExample)
BG (1) BG104726A (enExample)
BR (1) BR9907655A (enExample)
CA (1) CA2320388C (enExample)
DE (1) DE69932920T2 (enExample)
DZ (1) DZ2717A1 (enExample)
EA (1) EA003137B1 (enExample)
ES (1) ES2268847T3 (enExample)
GT (1) GT199900011A (enExample)
HR (1) HRP20000529B1 (enExample)
HU (1) HUP0100832A3 (enExample)
IL (1) IL137330A0 (enExample)
IS (1) IS5562A (enExample)
MA (1) MA26603A1 (enExample)
MY (1) MY133125A (enExample)
NO (1) NO20003965D0 (enExample)
NZ (1) NZ505724A (enExample)
OA (1) OA11448A (enExample)
PA (1) PA8467301A1 (enExample)
PE (1) PE20000243A1 (enExample)
PL (1) PL342817A1 (enExample)
SK (1) SK11262000A3 (enExample)
TN (1) TNSN99013A1 (enExample)
TR (1) TR200002248T2 (enExample)
TW (1) TW470744B (enExample)
UA (1) UA57824C2 (enExample)
WO (1) WO1999040061A2 (enExample)
YU (1) YU47100A (enExample)
ZA (1) ZA99873B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360672A1 (en) * 1999-01-29 2000-08-03 Wayne W. Hancock Methods for preventing graft rejection and ischemia-reperfusion injury
BR0013469B1 (pt) * 1999-08-20 2011-01-25 amidas aromáticas heterocìclicas fungicidas, composição fungicida compreendendo as mesmas, bem como método para o controle ou a prevenção de infestação fúngica.
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
KR20050009776A (ko) * 2000-02-04 2005-01-25 화이자 프로덕츠 인코포레이티드 헤테로사이클릭 아미드 유도체
US6740636B2 (en) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
ES2333645T3 (es) * 2001-06-22 2010-02-25 Bend Research, Inc. Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros.
CZ20033456A3 (en) 2001-06-22 2004-07-14 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
BR0309932A (pt) * 2002-05-14 2005-02-09 Pfizer Prod Inc Métodos para a fabricação de derivados de diidro-furan-2-ona
JP2005530775A (ja) 2002-05-14 2005-10-13 ファイザー・プロダクツ・インク ジヒドロキシヘキサン酸誘導体、それらの中間体、および製法
CA2494776A1 (en) * 2002-08-12 2004-02-19 Pfizer Products Inc. Crystal forms of quinoxaline-2-carboxylic acid ¬4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl|-amide
AU2003249474A1 (en) 2002-08-12 2004-02-25 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
ATE540671T1 (de) 2003-08-04 2012-01-15 Bend Res Inc Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
DK0708085T3 (da) * 1994-10-19 2002-11-11 Novartis Ag Antivirale ethere af aspartatproteasesubstrat-isostere
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
TW470744B (en) 2002-01-01
HRP20000529B1 (en) 2004-12-31
ES2268847T3 (es) 2007-03-16
IS5562A (is) 2000-07-14
OA11448A (en) 2003-11-18
WO1999040061A3 (en) 1999-10-21
JP3693916B2 (ja) 2005-09-14
WO1999040061A2 (en) 1999-08-12
HRP20000529A2 (en) 2001-08-31
MA26603A1 (fr) 2004-12-20
EA003137B1 (ru) 2003-02-27
JP2002502839A (ja) 2002-01-29
DE69932920D1 (de) 2006-10-05
BG104726A (en) 2001-04-30
DE69932920T2 (de) 2007-02-08
ZA99873B (en) 2000-08-04
NO20003965D0 (no) 2000-08-04
AP9901457A0 (en) 1999-03-31
CN1177834C (zh) 2004-12-01
NZ505724A (en) 2003-02-28
ATE337307T1 (de) 2006-09-15
PL342817A1 (en) 2001-07-02
CA2320388C (en) 2005-05-03
MY133125A (en) 2007-10-31
PA8467301A1 (es) 2000-05-24
IL137330A0 (en) 2001-07-24
NO20003965L (enExample) 2000-10-03
CN1290255A (zh) 2001-04-04
AU1778999A (en) 1999-08-23
SK11262000A3 (sk) 2001-01-18
EP1051405A2 (en) 2000-11-15
TNSN99013A1 (fr) 2005-11-10
DZ2717A1 (fr) 2003-09-01
HUP0100832A2 (hu) 2002-02-28
EP1051405B1 (en) 2006-08-23
HUP0100832A3 (en) 2002-03-28
PE20000243A1 (es) 2000-04-07
CA2320388A1 (en) 1999-08-12
BR9907655A (pt) 2000-10-24
GT199900011A (es) 2000-07-20
EA200000741A1 (ru) 2001-02-26
YU47100A (sh) 2002-11-15
KR20010040684A (ko) 2001-05-15
AP992A (en) 2001-08-06
HK1034969A1 (en) 2001-11-09
KR100385529B1 (ko) 2003-05-27
AR016175A1 (es) 2001-06-20
UA57824C2 (uk) 2003-07-15
AU752407B2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
CY2473B1 (en) New phenanthridines.
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MY121294A (en) Novel hexanoic acid derivatives.
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
TR199901754T2 (xx) Helicobacter pylori enfeksiyonlar�n�n ve bunlarla ba�lant�l� gastro-duodenal rahats�zl�klar�n tedavisinde
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
IT1285770B1 (it) Composti corticoidei
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
MY115211A (en) Novel amino acid derivatives, their preparation and use
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE69530988D1 (de) Benzimidazolderivate mit dopaminerger wirkung
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
TR199901386T2 (en) �midazopiridazinler.
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
TR199900013T2 (xx) Yeni bile�ikler.
ATE241640T1 (de) Fusidinsäure-derivate